Data on Bacillus Calmette-Guerin Vaccines Detailed by Researchers at Columbia University (Neo-adjuvant Immunotherapies: Bladder Cancer As a Platform for Drug Development Targeting Mucosal Immunity).

Keywords: New York City; State:New York; United States; North and Central America; BCG Therapy; BCG Vaccines; Bacillus Calmette-Guerin (BCG); Bacillus Calmette-Guerin Vaccines; Bacterial Vaccines; Biological Products; Bladder Cancer; Cancer; Drug Development; Drugs and Therapies; Health and Medicine; Immunization; Immunization and Public Health; Immunotherapy; Oncology; Therapy; Tuberculosis Vaccines; Vaccines EN New York City State:New York United States North and Central America BCG Therapy BCG Vaccines Bacillus Calmette-Guerin (BCG) Bacillus Calmette-Guerin Vaccines Bacterial Vaccines Biological Products Bladder Cancer Cancer Drug Development Drugs and Therapies Health and Medicine Immunization Immunization and Public Health Immunotherapy Oncology Therapy Tuberculosis Vaccines Vaccines 21 21 1 07/03/23 20230703 NES 230703 2023 JUL 3 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Vaccine Week -- Researchers detail new data in Immunization and Public Health - Bacillus Calmette-Guerin Vaccines. Currently, a myriad of immuno-oncology compounds is under clinical evaluation in BCG-unresponsive and BCG-naive patients as an alternative therapy in the context of worldwide BCG shortages. [Extracted from the article]